Alexander Hieu Nguyen - Mar 27, 2025 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Role
CLO and Head of Ops
Signature
/s/ Alexander Hieu Nguyen
Stock symbol
UBX
Transactions as of
Mar 27, 2025
Transactions value $
-$2,267
Form type
4
Date filed
3/31/2025, 04:19 PM
Previous filing
Feb 5, 2025
Next filing
Apr 3, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UBX Common Stock, $0.0001 par value Sale -$2.27K -1.95K -7.96% $1.16 22.6K Mar 27, 2025 Direct F1, F2
transaction UBX Common Stock, $0.0001 par value Award $0 +44K +194.65% $0.00 66.6K Mar 28, 2025 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UBX Stock Option (Right to Buy) Award $0 +73K $0.00 73K Mar 28, 2025 Common Stock 73K $1.67 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
F2 Includes Restricted Stock Units ("RSUs") that vest over time measured from the grant date.
F3 On January 30, 2024, the Board of Directors granted the Reporting Person 44,000 RSUs that vest in full upon the satisfaction of certain performance criteria, which were met on March 28, 2025.
F4 Includes RSUs that vest over time measured from the grant date.
F5 On January 30, 2024, the Board of Directors granted the Reporting Person an option to purchase 73,000 shares of common stock. The underlying shares vest and become exercisable pursuant to the following schedule: one half of the shares subject to the option vest upon the satisfaction of certain performance criteria, which were met on March 28, 2025, and the remaining shares subject to the option vest in 12 successive, equal monthly installments thereafter until fully vested, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.